Cargando…
The changing landscape of biosimilars in rheumatology
Biosimilars remain a hot topic in rheumatology, and some physicians are cautious about their application in the real world. With many products coming to market and a wealth of guidelines and recommendations concerning their use, there is a need to understand the changing landscape and the real clini...
Autores principales: | Dörner, Thomas, Strand, Vibeke, Cornes, Paul, Gonçalves, João, Gulácsi, László, Kay, Jonathan, Kvien, Tore K, Smolen, Josef, Tanaka, Yoshiya, Burmester, Gerd R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893105/ https://www.ncbi.nlm.nih.gov/pubmed/26964144 http://dx.doi.org/10.1136/annrheumdis-2016-209166 |
Ejemplares similares
-
Era of biosimilars in rheumatology: reshaping the healthcare environment
por: Smolen, Josef S, et al.
Publicado: (2019) -
The Rituximab Biosimilar CT-P10 in Rheumatology and Cancer: A Budget Impact Analysis in 28 European Countries
por: Gulácsi, László, et al.
Publicado: (2017) -
Erratum to: The Rituximab Biosimilar CT-P10 in Rheumatology and Cancer: A Budget Impact Analysis in 28 European Countries
por: Gulácsi, László, et al.
Publicado: (2017) -
Biosimilars in rheumatology: what the clinician should know
por: Castañeda-Hernández, Gilberto, et al.
Publicado: (2015) -
Biosimilars in rheumatology: understanding the rigor of their development
por: Goel, Niti, et al.
Publicado: (2017)